A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
PHASE1
This is a pilot clinical trial investigating the addition of haploidentical...
Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)
PHASE2
Targeted Natural Killer (NK) cell based adoptive immunotherapy for the trea...
Status
Completed
Location
Klinikum rechts der Isar, Strahlentherapie und Radiologische Onkologie
Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer
PHASE2
Background:
Immunotherapy is a powerful tool in the fight against cancer. ...